Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Publications: group B Streptococcus

2000 to Present:

  • Kim SY, Russell L, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine. 2014; 32(17):1954-63.
  • Park C, Nichols M., Schrag, SJ. Two Cases of Invasive Vancomycin-Resistant Group B Streptococcus Infection. New Engl J Med 2014; 370(9):885-86.
  • Verani J, Spina NL, Lynfield R, Schaffner W, Harrison LH, Holst A, Thomas S, Garcia JM, Scherzinger K, Aragon D, Petit S, Thompson J, Pasutti L, Carey R, McGee L, Weston E, Schrag SJ. Early-Onset Group B Streptococcal Disease in the United States: Potential for Further Reduction. Obstet Gynecol. 2014; 123(4): 828-37.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2013 [1 page].
  • Fairlie T, Zell ER, Schrag SJ.  Effectiveness of Intrapartum Antibiotic Prophylaxis for Prevention of Early-Onset Group B Streptococcal Disease. Obstet Gynecol. 2013;121(3):570-7.
  • Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.  Vaccine. 2013 Aug 28;31 Suppl 4:D52-7. doi: 10.1016/j.vaccine.2013.02.029.
  • Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013;31(Suppl 4):D20-6.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2012 [1 page].
  • Koumans EH, Rosen J, Van Dyke MK, Zell E, Phares CR, Taylor A, Loft J, and Schrag S for the ABCs and DHAP/RTI team. Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004. Am J of Obstet Gynecology. 2012;206(2):158.e1-158.e11.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2011.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2010.
  • Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease — Revised Guidelines from CDC, 2010. MMWR. 2010; Vol 59:RR-10.
  • Centers for Disease Control and Prevention. Trends in Perinatal Group B Streptococcal Disease – United States, 2000-2006. MMWR. 2009;58(5):109-12.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2009.
  • Kothari NJ, Morin CA, Glennen A, Jackson D, Harper J, Schrag SJ, Lynfield R. Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007. Emerg Infect Dis. 2009;15(8):1279-81.
  • Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis. 2009;49(1):85-92.
  • Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ. Evaluation of Universal Antenatal Screening for Group B Streptococcus. New Engl J Med. 2009; 360(25):2626-36.
  • Castor M, Whitney CG, Como-Sabetti K, Facklam R, Ferrieri P, Bartkus J, Juni B, Cieslak P, Farley M, Dumas N, Schrag SJ, and Lynfield R. Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates. Infect Dis Ob Gyn. 2008:727505,2008.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2008.
  • Dahesh S, Hensler ME, Van Sorge NM, Gertz RE Jr, Schrag S, Nizet V, Beall BW. Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to Beta-Lactam Antibiotics. Antimicrob Agents Chemother. 2008;52(8):2915-8.
  • Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K., Albanese BA, Schaffner W., Schrag SJ. Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multi-State, Population-Based Analysis. Ped Infect Dis J. 2008;27:1057-64.
  • Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag S. Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005. JAMA. 2008;299(17):2056-65.
  • Phares CR, Schuchat A, Schrag S.J. Invasive group B streptococcal disease in the United States. JAMA. 2008;300(14):1650.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2007.
  • Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ. Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005. JAMA. 2007; 299(17):2056-65.
  • Centers for Disease Control and Prevention. Perinatal Group B Streptococcal Disease After Universal Screening Recommendations -- United States, 2003-2005. MMWR. 2007;56(28):701-5.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2006.
  • Schrag SJ, Hadler J, Arnold KE, et al. Risk factors for invasive perinatal Escherichia coli sepsis in the era of widespread intrapartum antibiotic use. Pediatrics. 2006;118(2):570-6.
  • Schrag SJ, Stoll BJ. Early-onset neonatal sepsis in the era of wide-spread intrapartum chemoprophylaxis. Ped Infect Dis J. 2006;25(10):939-40.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2005.
  • Centers for Disease Control and Prevention. Early-Onset and Late-Onset Neonatal Group B Streptococcal Disease – United States, 1996-2004. MMWR. 2005;54(47):1205-8.
  • Eisenberg E, Craig AS, Gautam S et al. Prevention Strategies for Perinatal Group B Streptococcal Disease: Beyond Screening. Ped Infect Dis J. 2005;24:520-4.
  • Law MR, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, C, Reid T, Schrag S. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen. 2005;12:60-8.
  • Morin CA, White K, Schuchat A, Danila RN, Lynfield R. Perinatal group B streptococcal disease prevention, Minnesota. Emerg Infect Dis. 2005;11(9):1467-9.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2004.
  • Centers for Disease Control and Prevention. Diminishing Racial Disparities in Early-Onset Neonatal Group B Streptococcal Disease, United States, 2000-2003. MMWR. 2004;53(No.RR-23):502-5.
  • Centers for Disease Control and Prevention. Laboratory Practices for Prenatal Group B Streptococcal Disease. MMWR. 2004;53(No.RR-23):506-9.
  • Balter S, Zell ER, O’Brien K, Roome A, Noga H, Thayu M, Schuchat A. Impact of intrapartum antibiotics on the care and evaluation of the newborn. Pediatr Infect Dis. 2003;22:853-7.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2003.
  • Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis. 2003;3(4):201-13.
  • Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K, Noga H, Craig AS, Sanza LT, Smith G, Schuchat A. Prenatal Screening for Infectious Diseases and Opportunities for Prevention. Obstet Gynecol. 2003;102:753-60.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2002.
  • Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. MMWR. 2002;51(No.RR-11):1-22.
  • Hyde TB, Hilger TM, Reingold A, Farley MM, O’Brien KL, and Schuchat A for the Active Bacterial Core surveillance (ABCs) of the Emerging Infections Program Network. Trends in the incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110(4):690-5.
  • Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig A, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A. A population-based comparison of strategies to prevent early onset group B streptococcal disease in neonates. New Engl J Med. 2002;347:233-9.
  • Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O’Brien KL. Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Maternal Child Health J. 2002;6(2):107-14.
  • Baltimore RS, Huie SM, Meek JI, Schuchat A, O’Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 2001;108(5):1094-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2001.
  • Farley MM. Group B Streptococcal Infections in Nonpregnant Adults. Clin Infect Dis. 2001;33:556-61.
  • Henning KJ, Hall EL, Dwyer DM, Billmann L, Schuchat A, Johnson JA, Harrison LH. Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis. 2001;183:1138-42.
  • Schuchat A. Group B streptococcal infections: from trials and tribulations to triumph and trepidation. Clin Infect Dis. 2001;33:751-6.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2000.
  • Centers for Disease Control and Prevention. Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers- Connecticut and Minnesota. MMWR. 2000;49(11):228-32.
  • Centers for Disease Control and Prevention. Early-onset group B streptococcal disease, United States, 1998-1999. MMWR. 2000;49(35):793-6.
  • Centers for Disease Control and Prevention. Hospital-based policies for prevention of perinatal group B streptococcal disease, United States 1999. MMWR. 2000;49(41):936-40.
  • Factor SH, Whitney CG, Zywicki SS, Schuchat A for the Active Bacterial Core Surveillance Team. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. Obstet Gynecol. 2000;95:377-82.
  • Hager WD, Schuchat A, Gibbs R, Sweet R, Mead P, Larsen JW. Prevention of perinatal group B streptococcal infection: addressing current controversies. Obstet Gynecol. 2000;96:141-5.
  • Schrag S, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: How infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol. 2000:473-83.
  • Schrag SJ, Zywicki S, Farley M, Reingold A, Harrison L, Lefkowitz L, Hadler J, Danila R, Cieslak P, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.
  • Schuchat A, Schrag S. Group B Streptococcus: from emerging infection to prevention success story. In: Scheld WM, Craig WA, Hughes JM. Emerging Infections 4. Washington, DC: American Society for Microbiology. 2000:107-20.
 Top of Page

 1995-1999:

  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1999.
  • Centers for Disease Control and Prevention. Laboratory practices for prenatal group B streptococcal screening and reporting. MMWR. 1999;48(20):426-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1998.
  • Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease – United States, 1997. MMWR. 1998;47(32):665-70.
  • Harrison LH, Elliot JA, Libonati JP, Billmann L, Schuchat A, Dwyer DM, and the Maryland Bacterial Invasive Disease Surveillance Group. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis. 1998;177:998-1002.
  • Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. J Infect Dis. 1998;178:569-72.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1997.
  • Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease -- United States, 1993-1995. MMWR. 1997;46(21):473-7.
  • Rosenstein NE , Schuchat A, and the Neonatal Group B Streptococcal Disease Study Group. Opportunities for prevention of perinatal group B streptococcal disease: a multi-state surveillance analysis. Obstet Gynecol. 1997;90:901-6.
  • Whitney C, Plikaytis BD, Gozansky W, Schuchat A, Neonatal group B streptococcal disease study group. Prevention practices for perinatal group B streptococcal disease: a multistate surveillance analysis. Obstet Gynecol. 1997;89:28-32.
  • Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliott J, Facklam RR, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 1996;173:365-73.
  • Jackson L, Farley M, Schuchat A. Adult group B streptococcal disease. Ann Int Med. 1996;125;152-3.
  • Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR. 1996;45 (RR-7):1-24.
  • Farley MM. Group B Streptococcal Infection in Older Patients: Spectrum of Disease and Management Strategies. Drugs and Aging. 1995;6:293-300.
  • Harrison LH, Ali A, Dwyer DM, et al. Relapsing invasive group B streptococcal infection in adults. Ann Intern Med. 1995;123:421-7.
  • Jackson L, Hilsdon R, Farley M, Harrison L, Reingold A, Wenger JD, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995;123:415-20.
 Top of Page

1992-1994:

  • Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J. 1994;13:623-9.
  • Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, Wenger JD, et al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med. 1993;328:1807-11.
  • Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis. JAMA. 1993;270:1442-8.
  • Zangwill KM, Schuchat A, Wenger JD, and the Group B Streptococcal Disease Study Group. Group B streptococcal disease in the United States: Report from a multistate active surveillance system. MMWR. 1992;41[No. SS-6]:25-32.
 Top of Page
Top